top of page
Search
  • Writer's picturesiddhesh kapshikar
    • Dec 7, 2023
    • 5 min read

Gardasil (HPV Vaccine) Market, Global Outlook and Forecast 2023-2030

The global Gardasil (HPV Vaccine) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes


HPV is a group of viruses, the composition of a family, the virus morphology is similar, but the DNA restriction enzyme map is different, the nucleocapsid protein antigenicity is different.At present, there are about 100 types of HPV identified, which are divided into cutaneous HPV and genital epithelial HPV according to the location of the infected epithelium. About 35 types can infect the female genital tract, and about 20 types are related to tumors (the HPV infections mentioned below are all female genital tract infections).Don't according to different type of HPV and the risk level of the tumor is divided into low risk type don't and high risk type HPV, low risk HPV including HPV6, 11 type, 42, 43, 44, often cause genital warts and other benign lesions including cervical intraepithelial low-grade lesions (CIN I), and high risk type HPV including HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 type, and cervical cancer and cervical intraepithelial lesion (CIN II/III) related, especially HPV16 and 18 type.


This report aims to provide a comprehensive presentation of the global market for Gardasil (HPV Vaccine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gardasil (HPV Vaccine). This report contains market size and forecasts of Gardasil (HPV Vaccine) in global, including the following market information:


Global Gardasil (HPV Vaccine) Market Revenue, 2018-2023, 2024-2030, ($ millions)

Global Gardasil (HPV Vaccine) Market Sales, 2018-2023, 2024-2030, (K Units)

Global top five Gardasil (HPV Vaccine) companies in 2022 (%)

.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.

HPV 2 Valent Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Gardasil (HPV Vaccine) include GSK, MSD, Walvax Biotechnology and Wantai Biological Pharmacy, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Gardasil (HPV Vaccine) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gardasil (HPV Vaccine) Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)

Global Gardasil (HPV Vaccine) Market Segment Percentages, by Type, 2022 (%)


  • HPV 2 Valent Vaccine

  • HPV 4 Valent Vaccine

  • HPV 9 Valent Vaccine


Global Gardasil (HPV Vaccine) Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)

Global Gardasil (HPV Vaccine) Market Segment Percentages, by Application, 2022 (%)


  • Hpv16 Type

  • Hpv18 Type

  • High Risk Virus (Beside Hpv16,Hpv18)

  • Low Risk Virus


Global Gardasil (HPV Vaccine) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)

Global Gardasil (HPV Vaccine) Market Segment Percentages, By Region and Country, 2022 (%)


  • North America

  • US

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Nordic Countries

  • Benelux

  • Rest of Europe

  • Asia

  • China

  • Japan

  • South Korea

  • Southeast Asia

  • India

  • Rest of Asia

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • Turkey

  • Israel

  • Saudi Arabia

  • UAE

  • Rest of Middle East & Africa


Competitor Analysis

The report also provides analysis of leading market participants including:


  • Key companies Gardasil (HPV Vaccine) revenues in global market, 2018-2023 (Estimated), ($ millions)

  • Key companies Gardasil (HPV Vaccine) revenues share in global market, 2022 (%)

  • Key companies Gardasil (HPV Vaccine) sales in global market, 2018-2023 (Estimated), (K Units)

  • Key companies Gardasil (HPV Vaccine) sales share in global market, 2022 (%)


Further, the report presents profiles of competitors in the market, key players include:


  • GSK

  • MSD

  • Walvax Biotechnology

  • Wantai Biological Pharmacy


Outline of Major Chapters:

Chapter 1: Introduces the definition of Gardasil (HPV Vaccine), market overview.

Chapter 2: Global Gardasil (HPV Vaccine) market size in revenue and volume.

Chapter 3: Detailed analysis of Gardasil (HPV Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gardasil (HPV Vaccine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Gardasil (HPV Vaccine) capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Table of content

1 Introduction to Research & Analysis Reports 1.1 Gardasil (HPV Vaccine) Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Gardasil (HPV Vaccine) Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Gardasil (HPV Vaccine) Overall Market Size 2.1 Global Gardasil (HPV Vaccine) Market Size: 2022 VS 2030 2.2 Global Gardasil (HPV Vaccine) Revenue, Prospects & Forecasts: 2018-2030 2.3 Global Gardasil (HPV Vaccine) Sales: 2018-2030 3 Company Landscape 3.1 Top Gardasil (HPV Vaccine) Players in Global Market 3.2 Top Global Gardasil (HPV Vaccine) Companies Ranked by Revenue 3.3 Global Gardasil (HPV Vaccine) Revenue by Companies 3.4 Global Gardasil (HPV Vaccine) Sales by Companies 3.5 Global Gardasil (HPV Vaccine) Price by Manufacturer (2018-2023) 3.6 Top 3 and Top 5 Gardasil (HPV Vaccine) Companies in Global Market, by Revenue in 2022 3.7 Global Manufacturers Gardasil (HPV Vaccine) Product Type 3.8 Tier 1, Tier 2 and Tier 3 Gardasil (HPV Vaccine) Players in Global Market 3.8.1 List of Global Tier 1 Gardasil (HPV Vaccine) Companies 3.8.2 List of Global Tier 2 and Tier 3 Gardasil (HPV Vaccine) Companies 4 Sights by Product 4.1 Overvi

0 views0 comments

Recent Posts

See All

Comentarios

bottom of page